Pharmacological characteristics and clinical results of efinaconazole (Clenafin® Topical Solution 10%), a novel anti-onychomycosis drug
Gespeichert in:
| Veröffentlicht in: | Folia Pharmacologica Japonica 2015, Vol.145(5), pp.250-258 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 258 |
|---|---|
| container_issue | 5 |
| container_start_page | 250 |
| container_title | Folia Pharmacologica Japonica |
| container_volume | 145 |
| creator | Tatsumi, Yoshiyuki |
| description | |
| doi_str_mv | 10.1254/fpj.145.250 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1680208508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1680208508</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2270-85041b2add4e0454903696ae3c75564409a785df3684fb2322abeee1b41bf2e83</originalsourceid><addsrcrecordid>eNo9kduKFDEQhoMo7rDulfeSG2FFe8yxD1cigydYUHC9DtXp6tks6WRMuoXxCXwaH8InM7OzO1ehUl_9BV8R8pyzNRdavR13t2uu9Fpo9oisuFRN1cqueUxWjHFd6brjZ-QiZ9czphvR1JI_JWdCd7rtuFyRP99uIE1go49bZ8FTW2qwMyaXZ2czhTBQ6124aybMi58zjSPF0YUyFuB39EgvNx4DlK9_f-l13N3B36NfZhcD5ezlqzcUaIi_0JfA2VUx7O1NnPY2ZpfpkJbtM_JkBJ_x4v49Jz8-frjefK6uvn76snl_VVkhGla1mineCxgGhUxp1TFZdzWgtI3WtVKsg6bVwyjrVo29kEJAj4i8L1OjwFaek8tj7i7Fnwvm2UwuW_QeAsYlG163TLCy5oC-PqI2xZwTjmaX3ARpbzgzB_um2DfFvin2C_3iPnjpJxxO7IPrArw7Ard5hi2eAEhFtMdTmH6IPHUONzEY5H-_LJi_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1680208508</pqid></control><display><type>article</type><title>Pharmacological characteristics and clinical results of efinaconazole (Clenafin® Topical Solution 10%), a novel anti-onychomycosis drug</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Tatsumi, Yoshiyuki</creator><creatorcontrib>Tatsumi, Yoshiyuki</creatorcontrib><identifier>ISSN: 0015-5691</identifier><identifier>EISSN: 1347-8397</identifier><identifier>DOI: 10.1254/fpj.145.250</identifier><identifier>PMID: 25958913</identifier><language>eng ; jpn</language><publisher>Japan: The Japanese Pharmacological Society</publisher><subject>Animals ; Antifungal Agents - administration & dosage ; Antifungal Agents - chemistry ; Antifungal Agents - therapeutic use ; Clinical Trials as Topic ; Drug Resistance ; Humans ; Onychomycosis - drug therapy ; Pharmaceutical Solutions - administration & dosage ; Pharmaceutical Solutions - chemistry ; Pharmaceutical Solutions - therapeutic use ; Triazoles - administration & dosage ; Triazoles - chemistry ; Triazoles - therapeutic use</subject><ispartof>Folia Pharmacologica Japonica, 2015, Vol.145(5), pp.250-258</ispartof><rights>2015 by The Japanese Pharmacological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2270-85041b2add4e0454903696ae3c75564409a785df3684fb2322abeee1b41bf2e83</citedby><cites>FETCH-LOGICAL-c2270-85041b2add4e0454903696ae3c75564409a785df3684fb2322abeee1b41bf2e83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25958913$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tatsumi, Yoshiyuki</creatorcontrib><title>Pharmacological characteristics and clinical results of efinaconazole (Clenafin® Topical Solution 10%), a novel anti-onychomycosis drug</title><title>Folia Pharmacologica Japonica</title><addtitle>Nihon Yakurigaku Zasshi</addtitle><subject>Animals</subject><subject>Antifungal Agents - administration & dosage</subject><subject>Antifungal Agents - chemistry</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Clinical Trials as Topic</subject><subject>Drug Resistance</subject><subject>Humans</subject><subject>Onychomycosis - drug therapy</subject><subject>Pharmaceutical Solutions - administration & dosage</subject><subject>Pharmaceutical Solutions - chemistry</subject><subject>Pharmaceutical Solutions - therapeutic use</subject><subject>Triazoles - administration & dosage</subject><subject>Triazoles - chemistry</subject><subject>Triazoles - therapeutic use</subject><issn>0015-5691</issn><issn>1347-8397</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kduKFDEQhoMo7rDulfeSG2FFe8yxD1cigydYUHC9DtXp6tks6WRMuoXxCXwaH8InM7OzO1ehUl_9BV8R8pyzNRdavR13t2uu9Fpo9oisuFRN1cqueUxWjHFd6brjZ-QiZ9czphvR1JI_JWdCd7rtuFyRP99uIE1go49bZ8FTW2qwMyaXZ2czhTBQ6124aybMi58zjSPF0YUyFuB39EgvNx4DlK9_f-l13N3B36NfZhcD5ezlqzcUaIi_0JfA2VUx7O1NnPY2ZpfpkJbtM_JkBJ_x4v49Jz8-frjefK6uvn76snl_VVkhGla1mineCxgGhUxp1TFZdzWgtI3WtVKsg6bVwyjrVo29kEJAj4i8L1OjwFaek8tj7i7Fnwvm2UwuW_QeAsYlG163TLCy5oC-PqI2xZwTjmaX3ARpbzgzB_um2DfFvin2C_3iPnjpJxxO7IPrArw7Ard5hi2eAEhFtMdTmH6IPHUONzEY5H-_LJi_</recordid><startdate>201505</startdate><enddate>201505</enddate><creator>Tatsumi, Yoshiyuki</creator><general>The Japanese Pharmacological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201505</creationdate><title>Pharmacological characteristics and clinical results of efinaconazole (Clenafin® Topical Solution 10%), a novel anti-onychomycosis drug</title><author>Tatsumi, Yoshiyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2270-85041b2add4e0454903696ae3c75564409a785df3684fb2322abeee1b41bf2e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; jpn</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Antifungal Agents - administration & dosage</topic><topic>Antifungal Agents - chemistry</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Clinical Trials as Topic</topic><topic>Drug Resistance</topic><topic>Humans</topic><topic>Onychomycosis - drug therapy</topic><topic>Pharmaceutical Solutions - administration & dosage</topic><topic>Pharmaceutical Solutions - chemistry</topic><topic>Pharmaceutical Solutions - therapeutic use</topic><topic>Triazoles - administration & dosage</topic><topic>Triazoles - chemistry</topic><topic>Triazoles - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tatsumi, Yoshiyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Folia Pharmacologica Japonica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tatsumi, Yoshiyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacological characteristics and clinical results of efinaconazole (Clenafin® Topical Solution 10%), a novel anti-onychomycosis drug</atitle><jtitle>Folia Pharmacologica Japonica</jtitle><addtitle>Nihon Yakurigaku Zasshi</addtitle><date>2015-05</date><risdate>2015</risdate><volume>145</volume><issue>5</issue><spage>250</spage><epage>258</epage><pages>250-258</pages><issn>0015-5691</issn><eissn>1347-8397</eissn><cop>Japan</cop><pub>The Japanese Pharmacological Society</pub><pmid>25958913</pmid><doi>10.1254/fpj.145.250</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0015-5691 |
| ispartof | Folia Pharmacologica Japonica, 2015, Vol.145(5), pp.250-258 |
| issn | 0015-5691 1347-8397 |
| language | eng ; jpn |
| recordid | cdi_proquest_miscellaneous_1680208508 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Animals Antifungal Agents - administration & dosage Antifungal Agents - chemistry Antifungal Agents - therapeutic use Clinical Trials as Topic Drug Resistance Humans Onychomycosis - drug therapy Pharmaceutical Solutions - administration & dosage Pharmaceutical Solutions - chemistry Pharmaceutical Solutions - therapeutic use Triazoles - administration & dosage Triazoles - chemistry Triazoles - therapeutic use |
| title | Pharmacological characteristics and clinical results of efinaconazole (Clenafin® Topical Solution 10%), a novel anti-onychomycosis drug |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T08%3A14%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacological%20characteristics%20and%20clinical%20results%20of%20efinaconazole%20(Clenafin%C2%AE%20Topical%20Solution%2010%25),%20a%20novel%20anti-onychomycosis%20drug&rft.jtitle=Folia%20Pharmacologica%20Japonica&rft.au=Tatsumi,%20Yoshiyuki&rft.date=2015-05&rft.volume=145&rft.issue=5&rft.spage=250&rft.epage=258&rft.pages=250-258&rft.issn=0015-5691&rft.eissn=1347-8397&rft_id=info:doi/10.1254/fpj.145.250&rft_dat=%3Cproquest_cross%3E1680208508%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1680208508&rft_id=info:pmid/25958913&rfr_iscdi=true |